SHLD2P3: A Potential Drug Target for Cellular Processes and Diseases

Target Name: SHLD2P3

NCBI ID: G439965

SHLD2P3

Other Name(s): FAM35DP | SHLD2P3 variant 1 | FAM35B2 | Shieldin complex subunit 2 pseudogene 3, transcript variant 1 | shieldin complex subunit 2 pseudogene 3

SHLD2P3: A Potential Drug Target for Cellular Processes and Diseases

SHLD2P3 (FAM35DP) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the family of struct domain proteins (FAM), which are a type of transmembrane protein that plays a crucial role in intracellular signaling.

SHLD2P3 is unique due to its structure and its localization to specific tissues. It consists of a 166 amino acid protein that contains a catalytic active site, a transmembrane region, and a cytoplasmic tail. The protein is expressed in the brain and is involved in the regulation of a wide range of cellular processes, including neuronal communication, inflammation, and stress response.

One of the key functions of SHLD2P3 is its role in intracellular signaling. It is a potent negative regulator of the protein kinase A尾4, which is a well-known neurotoxin that is involved in the development of Alzheimer's disease. In addition, SHLD2P3 is involved in the regulation of the protein kinase PDK4, which is involved in the development and progression of many types of cancer.

Another function of SHLD2P3 is its role in the regulation of inflammation. It is a potent regulator of the transcription factor Nrf2, which is involved in the regulation of cellular stress responses and inflammation. This suggests that SHLD2P3 may play a role in the regulation of inflammatory responses and the development of inflammatory diseases.

In addition to its role in intracellular signaling and inflammation, SHLD2P3 is also involved in the regulation of cell survival. It is a potent regulator of the protein p53, which is involved in the regulation of DNA damage repair and cell survival. This suggests that SHLD2P3 may play a role in the regulation of cellular aging and the development of age-related diseases.

Given its unique structure and its involvement in a wide range of cellular processes, SHLD2P3 is a promising drug target. Studies have shown that SHLD2P3 is highly expressed in various tissues of the brain and that it is involved in the regulation of a wide range of cellular processes. Additionally, SHLD2P3 is a potent negative regulator of the protein kinase A尾4 and is involved in the regulation of PDK4, which are known to be involved in the development and progression of many types of cancer. These properties make SHLD2P3 an attractive potential drug target for the development of new treatments for a wide range of diseases.

In conclusion, SHLD2P3 is a protein that is expressed in various tissues of the body and is involved in a wide range of cellular processes. Its unique structure and its localization to specific tissues make it a promising drug target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of SHLD2P3 in intracellular signaling and its potential as a drug target.

Protein Name: Shieldin Complex Subunit 2 Pseudogene 3

The "SHLD2P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHLD2P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets